Literature DB >> 3382535

Changes in histology and cell kinetics during the growth course of xenografted squamous cell carcinoma.

J Wennerberg1, R Willén, C Tropé.   

Abstract

Two xenografted tumor lines, established from squamous cell carcinomas of the head and neck, were studied with respect to the growth parameters of the Gompertz function and changes in growth rate, cell cycle phase distribution, and histologic pattern during the course of growth. The tumors were transplanted subcutaneously in the back. Both tumor lines exhibited growth curves compatible with Gompertzian growth. The parameters of the Gompertz function differed significantly between the tumor lines. Tumor volume doubling time also varied during the course of growth. Flow cytometric analysis of cell cycle phase distribution showed an initial decrease in the fraction of cells in S-phase, parallel with an increase in the fraction of cells in GO/1-phase. As much as 50% of the cells were mouse-derived in tumors less than 100 mm3 in volume, after which the proportion of mouse-derived cells decreased to below 10%. This variation correlated with changes in the histopathologic picture.

Entities:  

Mesh:

Year:  1988        PMID: 3382535     DOI: 10.1001/archotol.1988.01860190085030

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  3 in total

1.  Cell proliferation in human tumours growing in nude mice: renal cell carcinomas, larynx and hypopharynx carcinomas.

Authors:  B Maurer-Schultze; I D Bassukas; M Böswald; M Harasim
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

2.  Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeutics.

Authors:  Gary Mo; Frank Gibbons; Patricia Schroeder; Wojciech Krzyzanski
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

3.  Analysis of inter-patient variations in tumour growth rate.

Authors:  Esmaeil Mehrara; Eva Forssell-Aronsson
Journal:  Theor Biol Med Model       Date:  2014-05-20       Impact factor: 2.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.